HHV8 associated Kaposi's sarcoma during triple immunosuppressive treatment with cyclosporin A, azathioprine, and prednisolone for ocular Behçet's disease and complete remission of both disorders with interferon alpha.
Kötter
I
I
University Hospital, Department of Internal Medicine, Haematology, Oncology, Immunology and Rheumatology, Otfried-Müller-Str 10, D-72076 Tübingen, Germany. ina.koetter@med.uni-tuebingen.de
Aepinus
C
C
Graepler
F
F
Gärtner
V
V
Eckstein
A K
AK
Stübiger
N
N
Kaskas
B
B
Zierhut
M
M
Bültmann
B
B
Kandolf
R
R
Kanz
L
L
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000188:drug therapy*; D019288:Herpesvirus 8, Human / Q000302:isolation & purification*; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D008297:Male; D009894:Opportunistic Infections / Q000188:drug therapy / Q000276:immunology*; D011994:Recombinant Proteins; D012514:Sarcoma, Kaposi / Q000188:drug therapy / Q000276:immunology*
D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins